Antibiotic Prophylaxis Using Cefpirome Sulfate in Gynecologic Surgery and Elimination Rate of Enterococcus faecalis from the Vagina.
Seventy-five patients undergoing total abdominal hysterectomy were given 1g of cefpirome sulfate (CPR) intravenously twice daily from immediately after surgery through the second postoperative day (CPR group). The results were compared with data from our previous study (1984-1985) in which 85 patients were given either piperacillin, cefazolin, or cefmetazole in the same dosage pattern after the same surgery (PIPC-CEZ-CMZ group). In the CPR group, the incidence of postoperative infection, febrile morbidity, and a persistent temperature of ≥37.5°C after the seventh postoperative day was 0%, 6.7%, and 6.7%, respectively. In the PIPC-CEZ-CMZ group, these values were 1.2%, 4.7% and 8.2%, respectively. There were no significant differences between the two groups (chi-square test), and no evidence could be found that CPR was more beneficial. Unlike other cephems, CPR is reported to show in-vitro activity against Enterococcus faecalis, which is frequently found in the vagina after gynecologic surgery. In this study, the postoperative vaginal colonization rate of E. faecalis was 24% (18/75) in the CPR group, which was lower than that in patients given other cephems in another study (1985-1990), including cefazolin (6/18), cefapirin (CEPR) (8/16), cefmetazole (12/25), and latamoxef (6/10). The vaginal elimination rate of E. faecalis was 60% (6/10) in the CPR group, and this was significantly higher than that in patients who were given other cephems (0/14, P=0.0354, chi-square test). This elimination rate supported the in vitro data of CPR's high activity against E. faecalis.